Piper Sandler keeps its positive rating on Oscar Health but cuts the price target to $45.

Nov 6, 2026, 2:48 PM ETOpinionRead the original at tradingview.com

Neutral

Piper Sandler kept its positive rating on Oscar Health but lowered its price target from $48 to $45. Those signals point in different directions, and the report shares no new company results.

OSCR · Oscar Health

AI read · Neutral

The AI's read

Keeping a positive rating suggests Piper Sandler still sees promise in Oscar Health. Lowering its price estimate points the other way. The report gives no new facts about the company’s sales, costs, or customers, so it does not show a clear change in its business outlook.

Get alerts for OSCR

Follow Oscar Health (OSCR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for OSCR

Free on the App Store and Google Play, or on the web.